Y. Namiki

Tautomeric phenomenon of a novel potent immunosuppressant (FK506) in solution. I. Isolation and structure determination of tautomeric compounds.

S. Koda, T. Yasuda, Y. Namiki, 1993, The Journal of antibiotics.

Determination of the immunosuppressive drug tacrolimus in its dosage forms by high-performance liquid chromatography

S. Koda, T. Yasuda, Y. Namiki, 1995 .

Factors Affecting Tautomeric Phenomenon of a Novel Potent Immunosuppressant (FK506) on the Design for Injectable Formulation

S. Koda, T. Yasuda, Y. Namiki, 1995 .

Degradation kinetics and isomerization of cefdinir, a new oral cephalosporin, in aqueous solution. 1.

M. Fujioka, T. Yasuda, Y. Okamoto, 1996, Journal of pharmaceutical sciences.

Degradation kinetics and mechanisms of a new cephalosporin, cefixime, in aqueous solution.

Y. Okimura, S. Koda, Y. Namiki, 1987, Journal of pharmaceutical sciences.

Method development for the determination of cefdinir and its related substances by high-performance liquid chromatography.

M. Fujioka, T. Yasuda, Y. Okamoto, 1996, Journal of pharmaceutical and biomedical analysis.

Degradation kinetics and isomerization of cefdinir, a new oral cephalosporin, in aqueous solution. 2. Hydrolytic degradation pathway and mechanism for beta-lactam ring opened lactones.

M. Fujioka, T. Yasuda, Y. Okamoto, 1996, Journal of pharmaceutical sciences.